![]()
|
Report Date : |
03.03.2008 |
IDENTIFICATION
DETAILS
|
Name : |
PHARMA-Q (PTY) LTD |
|
|
|
|
Registered Office : |
50 Commando Road, Industria, JOHANNESBURG, Gauteng |
|
|
|
|
Country : |
South Africa |
|
|
|
|
Date of Incorporation : |
02.12.1997 |
|
|
|
|
Com. Reg. No.: |
1997/020825/07 |
|
|
|
|
Legal Form : |
Private Limited Company |
|
|
|
|
Line of Business : |
Manufacturers of pharmaceutical products e.g. capsules,
liquids, creams, ointments, injectables and eye drops |
RATING &
COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Slow |
|
|
|
|
Litigation : |
Clear |
PHARMA-Q (PTY) LTD
50 Commando Road
Industria
JOHANNESBURG
Gauteng
Private Bag X09
FLORIDA
1710
TELEPHONE NUMBER: 011 474 7400 / 474 1880
FAX NUMBER: 011 474 7420
100% MICRO HEALTHCARE (PTY) LTD
Formerly 100% CREATIVE OUTSOURCING SOLUTIONS INTERNATIONAL (PTY) LTD (COSI), having been changed in November 2005. The subject also previously traded as COSI PHARMACEUTICALS, however, the trading name has fallen away.
KIHUWI INVESTMENTS (PTY) LTD
A LESCH (Managing
Director)
D BREET
A MEHTA
NEDBANK, Business East Rand branch, account number 1288002882. It was stated that the subject enjoys group overdraft facilities to an extent of R5 million, secured by a cession of debtors. Utilisation is stated to fluctuate.
2 December 1997
Registration certificate number 1997/020825/07
The subject took over the factory of ADCOCK INGRAM PHARMACEUTICALS (PTY) LTD and only commenced operations in 1998.
4460173364
Manufacturers of pharmaceutical products e.g. capsules, liquids, creams, ointments, injectables and eye drops
The subject imports raw materials from the USA, UK and Spain and deals locally with the following suppliers:
ANCHOR RAND Johannesburg
AKULU MARCHON Johannesburg
CRODA CHEMICALS Johannesburg
CTP PACKAGING Johannesburg
CONSOL GLASS Pretoria
Pharmaceutical industry e.g. Adcock Ingram, Lever Brothers, etc
Agents throughout South Africa
None
400
None
The premises are reported to be leased.
R100 divided into 100 ordinary shares of R1 each
R100
The following estimated financial situation was submitted:
STOCK R 20 000 000
DEBTORS R 18 000 000
FIXED ASSETS net book value R 9 500 000
CREDITORS R 8 000 000
TURNOVER per annum R140 000 000
ENSLYNS, Bethlehem
AUGUST
EMERALD, Bethlehem
ACCOUNT HIGHEST AVERAGE TERMS PAYMENT EXPERIENCE
OPENED CREDIT CREDIT PATTERN
1. 4 yrs R500
000 R250 000 - 30 days 35
days Good
c/l R300 000
2. 1993 R600
000 R 30 000 30 days 30 days Good
c/l
3. 2003 R150
000 R 50 000 - 30 days 30 days Very Good
c/l R100 000
ACCOUNT HIGHEST AVERAGE TERMS PAYMENT EXPERIENCE
OPENED CREDIT CREDIT PATTERN
1. 4 yrs R100 000 R 50 000 30 days 30 days Good
2. 1993 R600 000 R500 000 30 days 30 days Good
3. 6 yrs R300 000 R100 000 30 days 30 days Good
ACCOUNT HIGHEST AVERAGE TERMS PAYMENT EXPERIENCE
OPENED CREDIT CREDIT PATTERN
1. 5 yrs R1 000 000 R300 000- 30 days 40-45 days Slow
c/l R700 000
2. Oct 1993 R 600 000 R600 000 30 days 30 days Excellent
c/l
3. Old acc Account on hold Problematic
This is an established company meeting its commitments slowly. We would prefer to see a figure of €30 000 dealt with on a letter of credit basis as the subject appears to be experiencing cash flow problems.
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)